Minimize development time with efficient design and optimization of all genetic components of your potential biotherapeutic. Confirm and optimize gene edits and functional vector elements at high- or low-throughput with highly specific gene expression, qPCR, and sequencing. Genetic variant analysis and highly sensitive dPCR can help to establish optimum therapeutic titration and identify even low levels of pathogen contaminants.

COL017457-pharma-bio_High-throughput-Screening-1897204018

High-throughput expression analysis
 

Streamline exploration of large libraries of constructs to explore genetic variants associated with genetic regulation of and response to your biopharmaceutical.

Explore custom gene expression arrays ›

COL017457-pharma-bio_Target-Validation-and-Disease-Modeling-585361916

Target validation and disease modeling

Transform development of new therapeutic approaches with gene knock-down and knock-up investigations and optimize performance with validated indels and variants.

Use Sanger sequencing for primary and secondary edits ›

COL017457-pharma-bio_Preclinical-Dosage-Toxicology-and-Safety-Testin-203004232

Preclinical dosage, toxicology, and safety testing

Accelerate vital studies to identify impacts of treatment on gene expression in animal models.
 

Explore our off-the shelf expression panels ›

Darren Roberts Customer Spotlight

Scientist Spotlight: Transcriptome analysis in tumors and response to therapy

In this conversation with Dr. Darren Roberts, he discusses challenges in conducting gene expression studies with DNA and RNA from FFPE tumor tissues. He also explains the importance of selecting the right technology for each sample and stage in the process.

Download spotlight ›


Related pages
 

pharma-bio-genetic-analysis-solutions-drug-discovery
pharma-bio-clinical-trials
pharma-bio-process-development
pharma-bio-manufacturing
biopharma-scientist-on-portal

QualTrak digital experience

Discover QualTrak qPCR and dPCR worfklows for mAbs, vaccines, and cell and gene therapies across biopharmaceutical development and manufacturing.
 

Explore now ›

monoclonal-antibody-development

Monoclonal antibody development

Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.

Learn more ›

TFS-055-GSS-R7_re

Innovative support and instrument expertise

We support you with exceptional services, remote tools, training, and OEM expertise we’ve spent 40 years curating.

Download flyer ›

Style Sheet for Global Design System
CMD SchemaApp code